Exploring new immune signaling enzymes that could help fight cancer
Discovery of cGAS-like signaling enzymes in innate immunity and disease
This study is looking at how special enzymes help our immune system fight cancer and other diseases, and by understanding how they work, we hope to find new ways to improve cancer treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Dana-Farber Cancer Inst NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11014625 on NIH RePORTER |
What this research studies
This research investigates how certain enzymes, known as cGAS-like signaling enzymes, play a role in the immune response to cancer and other diseases. By studying RNA second messengers produced in response to infections and cellular stress, the research aims to uncover new pathways that could enhance our understanding of immune function. The team will utilize innovative methods to identify and characterize these enzymes, potentially leading to new therapeutic strategies for cancer treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with various types of cancer who may benefit from new immune-based therapies.
Not a fit: Patients with non-cancerous conditions or those who do not have a significant immune response may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of novel treatments that enhance the immune system's ability to fight cancer.
How similar studies have performed: Other research has shown promising results in targeting immune signaling pathways for cancer treatment, indicating that this approach has potential for success.
Where this research is happening
Boston, United States
- Dana-Farber Cancer Inst — Boston, United States (Active)
Researchers
- Principal investigator: Kranzusch, Philip J — Dana-Farber Cancer Inst
- Study coordinator: Kranzusch, Philip J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.